C/D/92/I-1) and for which consent has been given by a Commission Decision of 18 December 1992 for the placing on the market as a live vaccine for Aujeszky disease to be administered by intra-muscular application only, shall now also be given consent for intra-dermal application as well.
Article 2 This Decision is addressed to the Member States.
Done at Brussels, 18 July 1994.
For the Commission Yannis PALEOKRASSAS Member of the Commission (1) C (92) 3215 final.
